Corporate Banner
Satellite Banner
Automation & Microfluidics
Scientific Community
Become a Member | Sign in
Home>News>This Article

VTT Speeds up Drug Development with More Advanced Microarray Technology

Published: Friday, May 27, 2011
Last Updated: Friday, May 27, 2011
Bookmark and Share
VTT has developed a method which allows a single microchip to be used to screen the functions of tens of thousands of genes simultaneously by means of RNA interference.

RNA interference technology, which is used in cell biology, has revolutionized functional research of the gene products in the last ten years.

VTT Technical Research Centre of Finland has developed a method which allows a single microchip to be used to screen the functions of tens of thousands of genes simultaneously by means of RNA interference.

Traditional methods only allow a few hundred genes to be screened with each microplate, and therefore the new method will accelerate VTT’s service offering in the field of drug development.

“VTT has already tested the method on a panel of almost one hundred cancer cell types and found it to be both efficient and reliable. We have used the method especially in breast cancer and prostate cancer studies,” explains Juha Rantala, a research scientist at VTT and the founder of the method.

The primary benefit of the method is that it allows such a large number of samples to be analyzed simultaneously, which saves both money and human resources, and speeds up research considerably. The findings of the study were published in March 2011 in BMC Genomics, a journal specializing in the methodologies of genetic research.

Miniaturized cell spot microarray techniques, which are used to analyze the functioning of cells, have featured in drug development at VTT for a few years now, and they are both an important research tool and a development priority.

Ultra-high throughput screening (UHTS) techniques are used at VTT to study how one gene or groups of genes regulate the cell activities, and how the cell functions promote health, or cause illnesses.

RNA interference technology allows genes to be “silenced” and thereby inhibit protein production of genes. Potential future use of RNAi technology includes also the diagnosis and treatment of illnesses.

The unique method developed by VTT is mostly used in genomic-scale analyses which have previously been very expensive. The new technology is believed to give VTT a competitive advantage in genome research which is of special interest of the drug industry.

Other potential applications include studying the combined effects of genes and drugs. Research scientists at VTT have also cited the method previously in a scientific publication focusing on the cell division of breast cancer cells. The method is believed to significantly boost VTT’s commercial activities with the drug industry.

Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More than 5,200+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
Robotic Cleaning Technique Could Automate Neuroscience Research
New robotic cleaning technique allows pipettes used in patch-clamping to be re-used up to 11 or more times.
Lab-on-a-Chip to Help Detect Cancer
In this podcast, we speak to Gustavo Stolovitsky to learn about his career and the work he is doing at IBM Research.
First Entirely 3D-printed Organ-on-a-Chip with Integrated Sensors
New approach to manufacturing may allow researchers to rapidly design organs-on-chips that match the properties of a specific disease or individual patient's cells.
3D-Printing in Science: Conference Co-Staged with LABVOLUTION
LABVOLUTION 2017 will have an added highlight of a simultaneous conference, "3D-Printing in Science".
Size Matters for Particles in Bloodstream
Research uncovers more information about how particles behave in the human bloodstream.
Lab-on-a-Chip Detects Effects of Poison
A fast and efficient mixer has been developed for testing the effect of toxic substances faster by using a new lab-on-a-chip.
Analytical Science Breakthrough Could Lead To Medical Revolution
A breakthrough in analytical science s could allow pharmaceutical research to be faster and more precise.
Point of Care Diagnostics - A Cautious Revolution
Advances in molecular biology, coupled with the miniaturization and improved sensitivity of assays and devices in general, have enabled a new wave of point-of-care (POC) or “bedside” diagnostics.
Analysing 10,000 Cells Simultaneously
New techniquethat traps 10,000 cells on a single chip has potential for cancer screening for individuals.
Puttng Cells Through Their Paces
An obstacle course for human lung cells could be the answer for better testing the effectiveness of potential new drugs.
Scroll Up
Scroll Down
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,200+ scientific videos